Concepedia

Ian F. Thomas

IF

Statistics

Publications

7

Citations

436

H-Index

7

Active since

2015

Affiliations

Cardiff University(Current)

University of Liverpool

Rigshospitalet

Nottingham University Hospitals NHS Trust

The Christie Hospital

Ian F. Thomas is an author at Cardiff University specializing in medicine, chemotherapy, and acute myeloid leukemia treatment.

Publications per year

2015–2022

7

Publications

7

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Blood · 2015 · 295 citations · Full text

, , +5

Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia

Mike Dennis, Nigel H. Russell, Robert K. Hills et al. · Blood · 2015 · 49 citations · Full text

, , +16

Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Journal of Clinical Oncology · 2020 · 28 citations · Full text

, , +17

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

Alan K. Burnett, Robert K. Hills, Olav Wendelboe Nielsen et al. · Leukemia · 2018 · 23 citations · Full text

, , +12

Randomized evaluation of quizartinib and low-dose ara-C vs low-dose ara-C in older acute myeloid leukemia patients

Mike Dennis, Ian F. Thomas, Cono Ariti et al. · Blood Advances · 2021 · 20 citations · Full text

, , +13

1–5 of 7